ChiCTR2100050197
尚未开始
/
/
/
2021-08-22
/
/
SUBSTANCE USE DISORDER WITH ANY TYPE OF PSYCHIATRIC DISORDERS
The effectiveness of MICM to improve medication adherence for dual-diagnosed patients
A pilot randomized controlled trial of integrative Motivational Interviewing and Contingency Management program (MICM) for dual-diagnosed patients to enhance psychiatric medication adherence
The proposed project will adopt a single-blinded, multi-centre pilot randomized controlled trial (RCT) design to determine the feasibility and preliminary effectiveness of a multi-model, integrative Motivational Interviewing and Contingency Management program (MICM), in comparison with the usual care (i.e., case management), at immediately after intervention and 3-months post-intervention. The following outcomes will be assessed: 1. medication adherence (primary outcome); and 2. psychiatric symptoms, frequency of substance abuse and psychiatric hospitalizations (secondary outcomes). Moreover, the perceived usefulness and areas of improvement of the MICM program will be evaluated to make necessary improvement in the future clinical application.
随机抽样
Ⅰ期
Block randomization with block size of 6-8 will be used to maintain a balanced number of participants in both groups (Efird, 2011). A sequence of group identifiers (I or C) based on computer-generated random codes is prepared in advance and put in serially numbered sealed opaque envelopes by a clerical&
The researcher who is also the intervention deliverer will not know which participant will be assigned to which group before opening of opaque envelope. After allocation has been done, both participants and researcher cannot be blinded.
SELF
/
43
/
2021-08-23
2022-12-31
/
1. Adults, aged 18-64 years Hong Kong residents; 2. Diagnosed with substance-use disorder and comorbid with at least one type of other mental disorder in the Diagnostic and Statistical Manual – fourth version (text revised) (DSM-IV-TR) / fifth version (DSM-5), or International Classification of Diseases – 10th (ICD-10) / 11th version (ICD-11); 3. Able to give written consent as recommended by psychiatrist and read/write Chinese language; 4. Being prescribed at least one type of oral psychiatric medication.;
登录查看1. Having organic psychiatric disorder AND/OR learning disability; 2. Having been prescribed depot-only (injection) medication or no medication; 3. Having visual, language or communication difficulties.;
登录查看N/A
/
TGF-β 胰腺导管腺癌
中国医药生物技术协会2025-06-18
肿瘤治疗性疫苗
医麦创新药2025-06-18
β-地中海贫血 β-地
医麦创新药2025-06-18
D&D Pharmatech Inc. GC GLP-1/GCG
药时空2025-06-18
MTAP PRMT5 AI
晶泰科技2025-06-18
肥胖 箕星 超重
箕星药业科技2025-06-18
β-地中海贫
邦耀实验室2025-06-18
抽动症 神经发育障碍 BD项目002
美柏资本2025-06-18